MedPath

STRIDES PHARMA SCIENCE LIMITED

🇮🇳India
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:0

Trial Phases

1 Phases

Phase 3:2

Drug Approvals

87

FDA:87

Drug Approvals

Gabapentin

Approval Date
Dec 11, 2024
FDA

LOSARTAN POTASSIUM

Approval Date
Apr 5, 2024
FDA

Ibuprofen

Approval Date
Apr 5, 2024
FDA

Acetazolamide

Approval Date
Feb 27, 2024
FDA

SEVELAMER CARBONATE

Approval Date
Feb 23, 2024
FDA

Cyclosporine

Approval Date
Feb 22, 2024
FDA

prednisone

Approval Date
Feb 19, 2024
FDA

prednisone

Approval Date
Feb 15, 2024
FDA

prednisone

Approval Date
Feb 14, 2024
FDA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 9
  • Next

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Phase 3
2 (100.0%)
No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.